Moreover, our study found significantly elevated levels of the chemokine CCL17 (TARC) and the cytokine IL-6 in cHL patients at DIA, both of which are known to play crucial roles in modulating the tumor microenvironment [39,40]. This evidence concerns the gene IL6 and neoplasm.